Pierre Francois SABOURET

Bosco G, Mszar R, Piro S, Sabouret P, Gallo A. Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia. Curr Atheroscler Rep. 2024 Jul 5. doi: 10.1007/s11883-024-01225-3. Epub ahead of print. PMID: 38965183.

Weckesser F, Rivero M, Conde D, Perez G, Zaidel E, Garmendia C, Sabouret P, Trivi M, Costabel JP. Ischaemic and haemorrhagic risk distribution in real-life patients with acute coronary syndromes. Acta Cardiol. 2024 Jun 18:1-6. doi: 10.1080/00015385.2024.2365606. Epub ahead of print. PMID: 38888102.

Spadafora L, Bernardi M, Sarto G, Simeone B, Forte M, D'Ambrosio L, Betti M, D'Amico A, Cammisotto V, Carnevale R, Bartimoccia S, Sabouret P, Zoccai GB, Frati G, Valenti V, Sciarretta S, Rocco E. Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex Patients. Am J Cardiovasc Drugs. 2024 Jun 10. doi: 10.1007/s40256-024-00652-6. Epub ahead of print. PMID: 38856965.

Bernardi M, Spadafora L, Andaloro S, Piscitelli A, Fornaci G, Intonti C, Fratta AE, Hsu CE, Kaziròd-Wolski K, Metsovitis T, Biondi-Zoccai G, Sabouret P, Marzetti E, Cacciatore S. Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults. J Clin Med. 2024 May 23;13(11):3064. doi: 10.3390/jcm13113064. PMID: 38892776; PMCID: PMC11173304.

Metsovitis, T., Bernardi, M., Bruckert, E., Fogacci, F., Cicero, A., Garcia-Zamora, S., Spadafora, L., Angoulvant, D., Biondi-Zoccai, G., and Sabouret, P. (2024). Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions. Archives of Medical Science. https://doi.org/10.5114/aoms/187841

Schnur A, Rav Acha M, Loutati R, Perel N, Taha L, Zacks N, Maller T, Karmi M, Bayya F, Levi N, Sabouret P, Fink N, Marmor D, Shuvy M, Glikson M, Asher E. Incidence of Ventricular Fibrillation and Sustained Ventricular Tachycardia Complicating Non-ST Segment Elevation Myocardial Infarction. J Clin Med. 2024 Apr 15;13(8):2286. doi: 10.3390/jcm13082286. PMID: 38673559; PMCID: PMC11050986.

Sabouret P, Barbato E, Montalescot G, Biondi-Zoccai G, Manzo-Silberman S. Remembering our friend Jean-Philippe Collet: a giant in cardiology, a gentleman in life. Minerva Cardiol Angiol. 2024 Mar 27. doi: 10.23736/S2724-5683.24.06559-1. Epub ahead of print. PMID: 38535986.

Strangio A, Leo I, Sabatino J, Brida M, Siracusa C, Carabetta N, Zaffino P, Critelli C, Laschera A, Spadea MF, Torella D, Sabouret P, De Rosa S. Is artificial intelligence the new kid on the block? Sustainable applications in cardiology. Vessel Plus 2024;8:12. http://dx.doi.org/10.20517/2574-1209.2023.123

Bruoha S, Galli M, Sabouret P, Yosefy C, Taha L, Gragnano F, Savage MP, Shuvy M, Biondi-Zoccai G, Glikson M, Asher E. Atherosclerotic Plaque Erosion: Mechanisms, Clinical Implications, and potential therapeutic Strategies - a review. J Cardiovasc Pharmacol. 2024 Feb 29. doi: 10.1097/FJC.0000000000001554. Epub ahead of print. PMID: 38421206.

Berthelot E, Eliahou L, Jagu A, Damy T, Hanon O, Hulot JS, Meune C, Roig C, Roubille F, Sabouret P, Logeart D, Mewton N. Peptides natriurétiques dans le diagnostic et le suivi de l’insuffisance cardiaque [Natriuretic peptides in the diagnosis and monitoring of heart failure]. Rev Prat. 2024 Feb;74(2):185-193. French. PMID: 38415425.

Bäck M, Banach M, Braunschweig F, De Rosa S, Flachskampf FA, Kahan T, Ketelhuth DFJ, Lancellotti P, Larsson SC, Mellbin L, Nagy E, Savarese G, Szummer K, Wahl D; European Heart Journal Open Section Editors. Editors' highlight picks from 2023 in EHJ Open. Eur Heart J Open. 2024 Feb 22;4(1):oeae008. doi: 10.1093/ehjopen/oeae008. PMID: 38390349; PMCID: PMC10882979.

Bernardi M, Paneni F, Sabouret P. Homocysteine: A futile comeback or a promising tool for the risk assessment of hypertensive patients? Eur J Prev Cardiol. 2024 Feb 10:zwae053. doi: 10.1093/eurjpc/zwae053. Epub ahead of print. PMID: 38339989.

Sabouret P, Santos RD. Coronary Artery Calcium Score in The Young: Is it Time to Update the Guidelines? Eur J Prev Cardiol. 2024 Feb 8:zwae050. doi: 10.1093/eurjpc/zwae050. Epub ahead of print. PMID: 38330237.

Fogacci F, Di Micoli V, Sabouret P, Giovannini M, Cicero AFG. Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense? J Clin Med. 2024 Jan 28;13(3):751. doi: 10.3390/jcm13030751. PMID: 38337445.

Spadafora L, Comandini GL, Giordano S, Polimeni A, Perone F, Sabouret P, Leonetti M, Cacciatore S, Cacia M, Betti M, Bernardi M, Zimatore FR, Russo F, Iervolino A, Aulino G, Moscardelli A. Blockchain technology in Cardiovascular Medicine: a glance to the future? Results from a social media survey and future perspectives. Minerva Cardiol Angiol. 2023 Nov 16. doi: 10.23736/S2724-5683.23.06457-8. Epub ahead of print. PMID: 37971710.

Sabouret P, Dib JC, Ecarnot F, Banach M, Lellouche N. Eligibility for icosapent ethyl in a French population of lcoronary outpatients with type 2 diabetes. 1/3 is eligible to EPA

Galli M, Andreotti F, Sabouret P, Gragnano F. 2023 ESC Guidelines on ACS: what is new in antithrombotic therapy? Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20:pvad065. doi: 10.1093/ehjcvp/pvad065. Epub ahead of print. PMID: 37738449.

Perone F, Bernardi M, Redheuil A, Mafrica D, Conte E, Spadafora L, Ecarnot F, Tokgozoglu L, Santos-Gallego CG, Kaiser SE, Fogacci F, Sabouret A, Bhatt DL, Paneni F, Banach M, Santos R, Biondi Zoccai G, Ray KK, Sabouret P. Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions. J Clin Med. 2023 Aug 26;12(17):5563. doi: 10.3390/jcm12175563. PMID: 37685628; PMCID: PMC10487991.

Taha MB, Javed Z, Nwana N, Acquah I, Satish P, Sharma G, Sabouret P, Cainzos-Achirica M, Nasir K. Body Mass Index and All-Cause and Cardiovascular Mortality in United States Adults With and Without Atherosclerotic Cardiovascular Disease: Findings from the National Health Interview Survey. Popul Health Manag. 2023 Aug;26(4):254-267. doi: 10.1089/pop.2022.0280. PMID: 37590068.

Cacciatore S, Spadafora L, Bernardi M, Galli M, Betti M, Perone F, Nicolaio G, Marzetti E, Martone AM, Landi F, Asher E, Banach M, Hanon O, Biondi-Zoccai G, Sabouret P. J Clin Med. 2023 Aug 11;12(16):5233. doi: 10.3390/jcm12165233. PMID: 37629275; PMCID: PMC10455820.

How CV imaging may guide the initiation of SGLT2i ? Editorial led by Stefano Figliozzi.
Figliozzi S, Sabouret P, Biondi-Zoccai G, Bernardi M.
PMID: 37487240 DOI: 10.1097/FJC.0000000000001454

Fysekidis M, Cosson E, Sabouret P, Takbou K, Sutton A, Charnaux N, Banu I, Testa A, Biondi-Zoccai G, Vicaut E, Valensi P. Minerva Cardiol Angiol. 2023 Jul 5. doi: 10.23736/S2724-5683.23.06139-2. Epub ahead of print. PMID: 37405711. Impact of Insulin analogs in combination with Metformin on CV functions in T2D patients.

Campos Cervera LV, Sabouret P, Bernardi M, Spadafora L, Banach M, Muñoz F, Viruel M, Zaidel EJ, Bonorino J, Perez G, Arbucci R, Costabel JP. Treatment adherence in patients without ST-elevation acute coronary syndrome. 2023 Jul 5. doi: 10.23736/S2724-5683.23.06345-7. Epub ahead of print. PMID: 37405714. Prevalence and impact of adherence of #CAD patients. Large argentinian registry

Management of CAD remains challenging. This narrative article provides an overview of several new broader strategies that have proven benefits by reducing MACE in combination with PCI.

Management of CAD remains challenging. This narrative article provides an overview of several new broader strategies that have proven benefits by reducing MACE in combination with PCI.

Sabouret P, Ecarnot F, Bhatt DL, Galli M. It's (not just) the Cholesterol, Stupid! Recent Lessons about Chronic Inflammation and Cardiovascular Risk. Eur J Prev Cardiol. 2023 May 9:zwad147. doi: 10.1093/eurjpc/zwad147. Epub ahead of print. PMID: 37158493.

Evaluation of an Antiplatelet Monitoring in Elderly Patients.

The objective of this study was to provide descriptive statistics on patterns of prasugrel usage in the outpatient setting in France. This retrospective study was conducted to describe treatment patterns for prasugrel in the outpatient setting in France using the Intercontinental Marketing Services (IMS) Disease Analyzer database,which collates electronic medical records updated by a nationally representative database of 1200 French general practitioners (GPs). Anonymous data were collected… Voir plus

The objective of this study was to provide descriptive statistics on patterns of prasugrel usage in the outpatient setting in France. This retrospective study was conducted to describe treatment patterns for prasugrel in the outpatient setting in France using the Intercontinental Marketing Services (IMS) Disease Analyzer database,which collates electronic medical records updated by a nationally representative database of 1200 French general practitioners (GPs). Anonymous data were collected prospectively at each follow-up visit. The study population consisted of patients with≥1 prescription for prasugrel in the outpatient setting from its launch date to 3 years post-launch. Patients were followed up from the date of the first prescription for prasugrel recorded in the database until they died, changed GP, or reached the end of the study, whichever came first. In France,
the IMS Disease Analyzer included 1052 patients receiving≥1 prescription of prasugrel from January 2010 until October 2012. Eighty-five percent of the population wasmale. Themean age was 58 years; 94.3% were age<75 years, and 95.0% weighed ≥60 kg. Of the total, 99.8% of patients were prescribed a dailymaintenance dose of 10 mg, and 0.2% had a history of transient ischemic attack/stroke. Concomitant medications were antiplatelet agents (100%; aspirin, 93.7%), lipid-lowering agents (90.1%), β-blockers (83.7%), angiotensin-converting enzyme inhibitors (62.2%), and anti-ulcer medications (55.1%). The results reflect good usage of prasugrel by French GPs in the outpatient setting, with excellent implementation of the Prasugrel European Summary Product Characteristics. Voir moins

Zeitouni M, Sabouret P, Kerneis M, Silvain J, Collet JP, Bruckert E, Montalescot G. 2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):324-333. doi: 10.1093/ehjcvp/pvaa077. PMID: 32652000.

Banach M, Reiner Z, Cicero AFG, Sabouret P, Viigimaa M, Sahebkar A, Postadzhiyan A, Gaita D, Pella D, Penson PE. 2022: the year in cardiovascular disease - the year of upfront lipid lowering combination therapy. Arch Med Sci. 2022 Nov 7;18(6):1429-1434. doi: 10.5114/aoms/156147. PMID: 36457968; PMCID: PMC9710261.

Schiele F, Farnier M, Krempf M, Bruckert E, Ferrières J; French Group. A consensus statement on lipid management after acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):532-543. doi: 10.1177/2048872616679791. Epub 2016 Nov 17. PMID: 27856518.

Halimi F, Sabouret P, Huberman JP, Ouazana L, Guedj D, Djouadi K, Dhanjal TS, Goette A, Lafont C, Lellouche N. Atrial fibrillation detection with long-term continuous Holter ECG recording in patients with high cardiovascular risk and clinical palpitations: the prospective after study. Clin Res Cardiol. 2022 Sep 28. doi: 10.1007/s00392-022-02109-9. Epub ahead of print. PMID: 36169720.

Collet JP, Cuisset T, Rangé G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrié D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthélémy O, Beygui F, Silvain J, Vicaut E, Montalescot G; ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med. 2012 Nov 29;367(22):2100-9. doi: 10.1056/NEJMoa1209979. Epub 2012 Nov 4. PMID: 23121439.

Biondi-Zoccai G, Pirlamarla P, Sabouret P, Kozhukhov S, Marchenko O, Hill JA, Mamas MA. Cardiovascular scholarly challenges following the Russian invasion of Ukraine. Minerva Cardiol Angiol. 2022 Oct;70(5):525-528. doi: 10.23736/S2724-5683.22.06102-6. Epub 2022 Mar 28. PMID: 35343175.

Collet JP, Silvain J, Kerneis M, Cuisset T, Meneveau N, Boueri Z, Barthélémy O, Rangé G, Cayla G, Belle EV, Elhadad S, Carrié D, Caussin C, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G; ARCTIC Investigators. Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-Generation. Clin Cardiol. 2016 Apr;39(4):192-200. doi: 10.1002/clc.22512. Epub 2016 Feb 16. PMID: 26880570; PMCID:… Voir plus

Collet JP, Silvain J, Kerneis M, Cuisset T, Meneveau N, Boueri Z, Barthélémy O, Rangé G, Cayla G, Belle EV, Elhadad S, Carrié D, Caussin C, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G; ARCTIC Investigators. Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-Generation. Clin Cardiol. 2016 Apr;39(4):192-200. doi: 10.1002/clc.22512. Epub 2016 Feb 16. PMID: 26880570; PMCID: PMC6490771. Voir moins

Sabouret P, Bocchino PP, Angelini F, D'Ascenzo F, Galati G, Fysekidis M, DE Ferrari GM, Fischman DL, Bhatt DL, Biondi-Zoccai G. Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis. Minerva Cardiol Angiol. 2023 Apr;71(2):199-207. doi: 10.23736/S2724-5683.22.05900-2. Epub 2022 Feb 23. PMID: 35195376.

Sabouret P, Savage MP, Fischman D, Costa F. Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients. Am J Cardiovasc Drugs. 2021 Jan;21(1):21-34. doi: 10.1007/s40256-020-00414-0. PMID: 32394296.

Sabouret P, Asseman P, Dallongeville J, Dujardin JJ, Philippe F, Herrmann MA, Montalescot G; CONNECT Study Investigators. Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients - the CONNECT Study. Arch Cardiovasc Dis. 2010 Aug-Sep;103(8-9):437-46. doi: 10.1016/j.acvd.2010.07.001. Epub 2010 Oct 27. PMID: 21074122.

Sabouret P, Spadafora L, Fischman D, Ullah W, Zeitouni M, Gulati M, De Rosa S, Savage MP, Costabel JP, Banach M, Biondi-Zoccai G, Galli M. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? Eur J Intern Med. 2023 Apr;110:1-9. doi: 10.1016/j.ejim.2022.12.008. Epub 2022 Dec 25. PMID: 36575107.

Sabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, Gibault Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T. Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance. Ann Cardiol Angeiol (Paris). 2022 Feb;71(1):41-52. doi: 10.1016/j.ancard.2021.05.004. Epub 2021 Jul 14. PMID: 34274113.

Rosenbaum D, Dallongeville J, Sabouret P, Bruckert E. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):871-5. doi: 10.1016/j.numecd.2012.04.012. Epub 2012 Jun 29. PMID: 22748604.

Sabouret P, Rushton-Smith SK, Kerneis M, Silvain J, Collet JP, Montalescot G. Dual antiplatelet therapy: optimal timing, management, and duration. Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):198-204. doi: 10.1093/ehjcvp/pvv015. Epub 2015 Mar 23. PMID: 27533996.

Collet JP, Silvain J, Barthélémy O, Rangé G, Cayla G, Van Belle E, Cuisset T, Elhadad S, Schiele F, Lhoest N, Ohlmann P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G; ARCTIC investigators. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet. 2014 Nov 1;384(9954):1577-85. doi: 10.1016/S0140-6736(14)60612-7. Epub 2014 Jul 15… Voir plus

Collet JP, Silvain J, Barthélémy O, Rangé G, Cayla G, Van Belle E, Cuisset T, Elhadad S, Schiele F, Lhoest N, Ohlmann P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Montalescot G; ARCTIC investigators. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial. Lancet. 2014 Nov 1;384(9954):1577-85. doi: 10.1016/S0140-6736(14)60612-7. Epub 2014 Jul 15. PMID: 25037988. Voir moins

Sulman D, Zeitouni M, Silvain J, Kerneis M, Guedeney P, Barthélémy O, Brugier D, Sabouret P, Lattuca B, Mertens E, Posson J, Procopi N, Salloum T, Collet JP, Montalescot G. ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 3;8(6):633-643. doi: 10.1093/ehjcvp/pvac021. PMID: 35381063.

Ullah W, Zahid S, Sandhyavenu H, Faisaluddin M, Khalil F, Pasha AK, Alraies MC, Cuisset T, Rao SV, Sabouret P, Savage MP, Fischman DL. Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):717-727. doi: 10.1093/ehjcvp/pvac020. PMID: 35325105.

Sabouret P, Angoulvant D, Pathak A. FOURIER to ODYSSEY: the end of the journey for lipid-lowering therapy trials? Lessons from recent clinical trials with anti-PCSK9 antibodies. EuroIntervention. 2018 Jun 20;14(2):144-146. doi: 10.4244/EIJY18M04_1. PMID: 29701178.

Schiele F, Sabouret P, Puymirat E, Abdennbi K, Lebeau F, Meltz M, Kownator S, Angoulvant D. French expert group proposal for lipid-lowering therapy in the first 3 months after acute myocardial infarction. Panminerva Med. 2023 Apr 6. doi: 10.23736/S0031-0808.22.04799-1. Epub ahead of print. PMID: 37021978.

Collet JP, Hulot JS, Cuisset T, Rangé G, Cayla G, Van Belle E, Elhadad S, Rousseau H, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthélémy O, Beygui F, Silvain J, Vicaut E, Montalescot G; ARCTIC investigators. Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study. Eur J Clin Pharmacol. 2015 Nov;71(11):1315-24. doi: 10.1007/s00228-015-1917-9. Epub 2015 Aug 13. PMID: 26265231.

Roussoulières AL, Schnetzler B, Sabouret P, Delcourt A, Ghossoub JJ, Dorent R, Beigelman C, Gandjbakhch I. Hematoma of the interventricular septum following right ventricular endomyocardial biopsy for the detection of allograft rejection after heart transplantation. J Heart Lung Transplant. 1999 Nov;18(11):1147-50. doi: 10.1016/s1053-2498(99)00086-8. PMID: 10598741.

Montalescot G, Rangé G, Silvain J, Bonnet JL, Boueri Z, Barthélémy O, Cayla G, Belle L, Van Belle E, Cuisset T, Elhadad S, Pouillot C, Henry P, Motreff P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Collet JP; ARCTIC Investigators. High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study. Circulation. 2014 May… Voir plus

Montalescot G, Rangé G, Silvain J, Bonnet JL, Boueri Z, Barthélémy O, Cayla G, Belle L, Van Belle E, Cuisset T, Elhadad S, Pouillot C, Henry P, Motreff P, Carrié D, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Beygui F, Vicaut E, Collet JP; ARCTIC Investigators. High on-treatment platelet reactivity as a risk factor for secondary prevention after coronary stent revascularization: A landmark analysis of the ARCTIC study. Circulation. 2014 May 27;129(21):2136-43. doi: 10.1161/CIRCULATIONAHA.113.007524. Epub 2014 Apr 9. PMID: 24718568. Voir moins

Sabouret P, Angoulvant D, Pathak A, Fysekidis M, Laterra G, Costa F, Angelini F, Bocchino PP, Montalescot G, Biondi-Zoccai G. How to fill the GAPS-I in secondary prevention: application of a strategy based on GLP1 analogues, antithrombotic agents, PCSK9 inhibitors, SGLT2 inhibitors and immunomodulators. Panminerva Med. 2022 Jun;64(2):265-273. doi: 10.23736/S0031-0808.21.04284-1. Epub 2021 Jun 1. PMID: 34060278.

Cohen C, Cohen R, Nasir K, Sabouret P. Letter to the Editor: Improvement of Coronary Calcium Scores After Bariatric Surgery in People with Severe Obesity. Obes Surg. 2022 May;32(5):1748-1749. doi: 10.1007/s11695-022-05899-z. Epub 2022 Jan 17. PMID: 35038112.

Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, Ecollan P, Combes X, Huber K, Pollack C Jr, Bénezet JF, Stibbe O, Filippi E, Teiger E, Cayla G, Elhadad S, Adnet F, Chouihed T, Gallula S, Greffet A, Aout M, Collet JP, Vicaut E; ATOLL Investigators. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet. 2011 Aug 20;378(9792):693-703… Voir plus

Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, Ecollan P, Combes X, Huber K, Pollack C Jr, Bénezet JF, Stibbe O, Filippi E, Teiger E, Cayla G, Elhadad S, Adnet F, Chouihed T, Gallula S, Greffet A, Aout M, Collet JP, Vicaut E; ATOLL Investigators. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet. 2011 Aug 20;378(9792):693-703. doi: 10.1016/S0140-6736(11)60876-3. PMID: 21856483. Voir moins

Liu Z, Silvain J, Kerneis M, Barthélémy O, Payot L, Choussat R, Sabouret P, Cohen M, Pollack CV Jr, Goldstein P, Zeymer U, Huber K, Vicaut E, Collet JP, Montalescot G. Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial. Angiology. 2017 Jan;68(1):29-39. doi: 10.1177/0003319716629541. Epub 2016 Feb 9. PMID: 26861858.

Sabouret P, Puymirat E, Kownator S, Abdennbi K, Lebeau F, Meltz M, Angoulvant D, Schiele F. Lipid-lowering treatment up to one year after acute coronary syndrome: guidance from a French expert panel for the implementation of guidelines in practice. Panminerva Med. 2022 Oct 12. doi: 10.23736/S0031-0808.22.04777-2. Epub ahead of print. PMID: 36222543.

Sabouret P, Angoulvant D, Ray KK. Lipoprotein(a), the rediscovered risk factor, or how to get "back to the future". Arch Cardiovasc Dis. 2020 Mar;113(3):147-151. doi: 10.1016/j.acvd.2020.03.008. Epub 2020 Mar 20. PMID: 32205042.

Sabouret P, Angoulvant D, Cannon CP, Banach M. Low levels of low-density lipoprotein cholesterol, intracerebral haemorrhage, and other safety issues: is there still a matter of debate? Eur Heart J Open. 2022 Jun 7;2(4):oeac038. doi: 10.1093/ehjopen/oeac038. PMID: 36117951; PMCID: PMC9472780.

Ullah W, Ali Z, Sadiq U, Rafiq A, Khan S, Mamas MA, Sabouret P, Fischman DL. Meta-Analysis Comparing the Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Am J Cardiol. 2020 Oct 1;132:22-28. doi: 10.1016/j.amjcard.2020.07.017. Epub 2020 Jul 17. PMID: 32771221.

Sabouret P, Denolle T, Krempf M, Om S, Laville M. Enquête MICROALB: dépistage de la microalbuminurie chez l'hypertendu diabétique de type 2 par le médecin généraliste en France métropolitaine [MICROALB study: screening for microalbuminuria in type 2 diabetic hypertensive patients by general practitioners in France]. Arch Mal Coeur Vaiss. 2006 Jul-Aug;99(7-8):712-7. French. PMID: 17061450.

Sabouret P, Biondi-Zoccai G, Banach M, Galli M. Modulation and personalization of therapy after acute coronary syndromes: the road to precision. Eur Heart J. 2023 Apr 17:ehad231. doi: 10.1093/eurheartj/ehad231. Epub ahead of print. PMID: 37062814.

Sabouret P, Bocchino PP, Biondi-Zoccai G. New anti-diabetic agents: major advances with unanswered questions. Rev Cardiovasc Med. 2020 Dec 30;21(4):489-492. doi: 10.31083/j.rcm.2020.04.220. PMID: 33387991.

Sabouret P, Taiel-Sartral M. New antiplatelet agents in the treatment of acute coronary syndromes. Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11. PMID: 24630752.

Angoulvant D, Sabouret P, Savage MP. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View. Am J Cardiovasc Drugs. 2021 Sep;21(5):483-486. doi: 10.1007/s40256-021-00471-z. Epub 2021 Mar 6. PMID: 33674980; PMCID: PMC8435520.

Girerd N, Leclercq C, Hanon O, Bayés-Genís A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F. Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. Rev Esp Cardiol (Engl Ed). 2023 Mar 11:S1885-5857(23)00073-7. English, Spanish. doi: 10.1016/j.rec.2023.03.005. Epub ahead of print. PMID: 36914024.

Richard P, Vayre F, Sabouret P, Gandjbakhch I, Ollivier JP. Devenir de l'insuffisance tricuspide traumatique opérée. A propos de neuf cas [Outcome of traumatic tricuspid insufficiency, treated surgically. Apropos of 9 cases]. Arch Mal Coeur Vaiss. 1997 Apr;90(4):451-6. French. PMID: 9238461.

Sabouret P, Farnier M, Puymirat E. Inhibiteurs de PCSK9 : quelle place dans la prise en charge actuelle des dyslipidémies ? [PCSK9 inhibitors: What place in the management of dyslipidemia?]. Presse Med. 2019 Mar;48(3 Pt 1):227-237. French. doi: 10.1016/j.lpm.2019.01.009. Epub 2019 Mar 8. PMID: 30853281.

Salem JE, Sabouret P, Funck-Brentano C, Hulot JS. Pharmacology and mechanisms of action of new oral anticoagulants. Fundam Clin Pharmacol. 2015 Feb;29(1):10-20. doi: 10.1111/fcp.12091. Epub 2014 Sep 25. PMID: 25196680.

Sabouret P, Cluzel P, Pavie A, Gandjbakhch I. Exclusion d'un anévrysme mycotique de siège hépatique par mise en place de "coils" [Picture of the month. Exclusion of a hepatic mycotic aneurysm by inserting of a coil]. Ann Cardiol Angeiol (Paris). 1998 Oct;47(8):595. French. PMID: 9809146.

Sabouret P, Pavie A, Bors V, Gandjbakhch I. L'image du mois. Kystes hydatiques de localisation cardiaque [Picture of the month. Hydatid cyst of cardiac localization]. Ann Cardiol Angeiol (Paris). 1998 Dec;47(10):767. French. PMID: 9922857.

Richard P, Sabouret P, Vayre F, Desrame J, Ollivier JP. Pleuropéricardite compliquée d'une tamponnade révélatrice d'une connectivite mixte. Régression sous anti-inflammatoires non stéroïdiens. A propos d'un Clinical case [Pleuropericarditis complicated of tamponade disclosing mixed connective tissue disease. Remission with non-steroidal anti-inflammatory agents. Apropos of a case]. Ann Cardiol Angeiol (Paris). 1996 Nov;45(9):513-5. French. PMID: 9033704.

Sabouret P, Lemesle G, Bellemain-Appaix A, Aubry P, Bocchino PP, Rafflenbeul E, Belle L, Nolan J, Bernardi M, Biondi-Zoccai G, Savage MP, Banach M, Cayla G. Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper. Arch Med Sci. 2022 Jun 23;18(4):839-854. doi: 10.5114/aoms/150321. PMID: 35832705; PMCID: PMC9266793.

Mewton N, Girerd N, Boffa JJ, Courivaud C, Isnard R, Juillard L, Lamblin N, Legrand M, Logeart D, Mariat C, Meune E, Sabouret P, Sebbag L, Rossignol P. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology. Arch Cardiovasc Dis. 2020 Oct;113(10):660-670. doi: 10.1016/j.acvd.2020.03.018. Epub 2020 Jul 11. PMID:… Voir plus

Mewton N, Girerd N, Boffa JJ, Courivaud C, Isnard R, Juillard L, Lamblin N, Legrand M, Logeart D, Mariat C, Meune E, Sabouret P, Sebbag L, Rossignol P. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology. Arch Cardiovasc Dis. 2020 Oct;113(10):660-670. doi: 10.1016/j.acvd.2020.03.018. Epub 2020 Jul 11. PMID: 32660835. Voir moins

Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF, ten Berg JM, Miller DL, Costigan TM, Goedicke J, Silvain J, Angioli P, Legutko J, Niethammer M, Motovska Z, Jakubowski JA, Cayla G, Visconti LO, Vicaut E, Widimsky P; ACCOAST Investigators. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013 Sep 12;369(11):999-1010. doi: 10.1056/NEJMoa1308075. Epub 2013 Sep 1. PMID: 23991622.

Zeitouni M, Sulman D, Silvain J, Kerneis M, Guedeney P, Barthelemy O, Brugier D, Sabouret P, Procopi N, Collet JP, Montalescot G. Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines. Heart. 2023 Mar 10;109(7):527-534. doi: 10.1136/heartjnl-2022-321688. PMID: 36270781.

Schiele F, Lemesle G, Angoulvant D, Krempf M, Kownator S, Cheggour S, Belle L, Ferrières J; French Group. Proposal for a standardized discharge letter after hospital stay for acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2020 Oct;9(7):788-801. doi: 10.1177/2048872619844444. Epub 2019 Apr 16. PMID: 30990337.

Michos ED, Sabouret P. Racial differences in Takotsubo cardiomyopathy: more alike than different? Minerva Cardiol Angiol. 2021 Dec;69(6):746-749. doi: 10.23736/S2724-5683.20.05571-1. Epub 2021 Jan 11. PMID: 33427430.

Sabouret P, Cacoub P, Dallongeville J, Krempf M, Mas JL, Pinel JF, Priollet P, Steg G, Taminau D, Montalescot G; REACH Registry investigators. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis. 2008 Feb;101(2):81-8. doi: 10.1016/s1875-2136(08)70263-8. PMID: 18398391.

Sabouret P, Depret-Bixio L, Cotte FE, Marie P, Bedira N, Blin P. Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. Clin Res Cardiol. 2014 Nov;103(11):887-93. doi: 10.1007/s00392-014-0726-y. Epub 2014 May 15. PMID: 24830515.

Bernardi M, Spadafora L, Galli M, Biondi-Zoccai G, Sabouret P. Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients? Arch Med Sci. 2023 Feb 3;19(2):528-531. doi: 10.5114/aoms/160006. PMID: 37034516; PMCID: PMC10074288.

Sabouret P, Galati G, Angoulvant D, Germanova O, Castelletti S, Pathak A, Metra M, Margonato A. The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management. Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):394-404. doi: 10.1093/ehjcvp/pvaa051. PMID: 32402065.

Charles D, Sabouret P, Moll A, Plisson M, Nasir K, Biondi-Zoccai G, Gulati M, Bhatt DL, Fysekidis M. The relationship between mortality and daily number of steps in type 2 diabetes. Panminerva Med. 2022 May 30. doi: 10.23736/S0031-0808.22.04732-2. Epub ahead of print. PMID: 35638241.

Spadafora L, Bernardi M, Galli M, Biondi-Zoccai G, Sabouret P. Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies. Arch Med Sci. 2022 Nov 7;18(6):1689-1692. doi: 10.5114/aoms/155411. PMID: 36457983; PMCID: PMC9710287.

Galati G, Sabouret P, Germanova O, Bhatt DL. Women and Diabetes: Preventing Heart Disease in a New Era of Therapies. Eur Cardiol. 2021 Oct 21;16:e40. doi: 10.15420/ecr.2021.22. PMID: 34777580; PMCID: PMC8576483.